Praetorian Bio was also represented at the World Vaccine Congress in Washington, D.C., one of the largest global gatherings dedicated to vaccine innovation. Our Co-CEO Ivo Ploemen presented the company’s vision for preventive and therapeutic mucosal vaccines addressing dental caries and periodontitis, two of the most prevalent chronic diseases worldwide.
The meeting connected us with vaccine developers, investors, strategic partners, and global health stakeholders, and reinforced a clear and growing recognition: oral health is central to overall health, and mucosal vaccination has a meaningful role to play in addressing some of its largest unmet needs.
Our presence at the World Vaccine Congress reflects Praetorian Bio’s commitment to advancing the science of mucosal immunization, building strategic partnerships, and accelerating vaccines with the potential to improve oral health for billions of people worldwide.
